Dr. Kirk A. Duncan, MD

Office and hospital visits

2016: 9972017: 52048%

Tests and treatments

2016: 5702017: 13077%

Medicare services

650vs 1,11742% below

Part D claims

110vs 37070% below

Medians across 50 nephrologists in Kansas with Dmand AI profiles that report each measure.

1. 99232Hospital inpatient care28344%: Services 283, Patients 105, Where In a facility
2. 99214Office visit, established patient11818%: Services 118, Patients 94, Where In an office
3. 90960Dialysis8513%: Services 85, Patients 20, Where In an office
4. 99222Hospital inpatient care619%: Services 61, Patients 54, Where In a facility
5. 90935Dialysis457%: Services 45, Patients 20, Where In a facility

CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.

1. Intralipid3431%: Claims 34, Generic name Fat Emulsions, Drug cost $5,170
2. Dextrose In Water3229%: Claims 32, Generic name Dextrose 5 % In Water, Drug cost $184
3. Prosol3229%: Claims 32, Generic name Parenteral Amino Acid 20% No.1, Drug cost $7,262
4. Furosemide1211%: Claims 12, Drug cost $63

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Claims for drugs CMS names

2017: 1,1532018: 11090%

Drugs named by CMS: 4 in 2018, 29 in 2017.

1. Mallinckrodt LLC$26033%: General payments $260, Payments 4, Years 2016 to 2017
2. Relypsa, Inc.$22428%: General payments $224, Payments 3, Years 2016 to 2017
3. Abbvie Inc.$12015%: General payments $120, Payments 1, Years 2025
4. Takeda Pharmaceuticals U.S.A., Inc.$9312%: General payments $93, Payments 1, Years 2016
5. Novartis Pharmaceuticals Corporation$7710%: General payments $77, Payments 1, Years 2017

Share is of all general payments to this clinician.